Switch to:
GuruFocus has detected 2 Warning Signs with Genomic Health Inc $GHDX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Genomic Health Inc (NAS:GHDX)
EV-to-EBITDA
-3,310.72 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Genomic Health Inc's enterprise value is $956.8 Mil. Genomic Health Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.3 Mil. Therefore, Genomic Health Inc's EV/EBITDA ratio for today is -3,310.72.

During the past 13 years, the highest EV/EBITDA Ratio of Genomic Health Inc was 939.60. The lowest was -3540.20. And the median was -20.20.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Genomic Health Inc's stock price is $30.61. Genomic Health Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.24. Therefore, Genomic Health Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Genomic Health Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=956.798/-0.289
=-3,310.72

Genomic Health Inc's current Enterprise Value is $956.8 Mil.
Genomic Health Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2017 was -2.912 (Jun. 2016 ) + -0.73 (Sep. 2016 ) + 3.771 (Dec. 2016 ) + -0.418 (Mar. 2017 ) = $-0.3 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Genomic Health Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=30.61/-0.24
=

Genomic Health Inc's share price for today is $30.61.
Genomic Health Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was -0.18 (Jun. 2016 ) + -0.08 (Sep. 2016 ) + 0.04 (Dec. 2016 ) + -0.02 (Mar. 2017 ) = $-0.24.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Genomic Health Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
ev2ebitda -22.38-46.30-235.2748.4942.0851.54-145.40-54.69-39.31-138.06

Genomic Health Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2ebitda -54.69-35.23-25.64-19.57-39.31-35.39-53.49-76.52-138.06-3,385.61
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK